Daniel Miller, MD
Ophthalmology · Cincinnati, OHNPI 1487681987
Payments from drug & device makers
Across 279 payments — averaging $8332.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2.2M
- Genentech USA, Inc.$28K
- Regeneron Healthcare Solutions, Inc.$15K
- Novartis$15K
- AbbVie$10K
- F. Hoffmann-la Roche AG$4K
- plus $6K from 13 others
Across 5 payments — averaging $2387.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$12K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 118 | $2,247,757 |
| Genentech USA, Inc. | 38 | $27,805 |
| Regeneron Healthcare Solutions, Inc. | 32 | $15,102 |
| Novartis | 10 | $14,508 |
| AbbVie(2 entities) | 17 | $9,793 |
| F. Hoffmann-la Roche AG | 1 | $4,139 |
| Alcon Research LLC | 1 | $3,850 |
| Otsuka America Pharmaceutical, Inc. | 23 | $455 |
| Apellis Pharmaceuticals, Inc. | 9 | $402 |
| Alimera Sciences, Inc. | 11 | $217 |
| Carl Zeiss Meditec USA, Inc. | 1 | $153 |
| Astellas Pharma US Inc | 5 | $150 |
| Alcon | 4 | $121 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Eyepoint US, Inc. | 2 | $72 |
| Johnson & Johnson | 3 | $49 |
| Glaukos Corporation | 1 | $35 |
| Lombart Brothers, Inc. | 1 | $30 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
How this compares
$2,324,757 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Cincinnati
- Michael SnyderCincinnati$1.3M
- Christopher RiemannCincinnati$985K
- Robert SiskCincinnati$831K
- Anup KhatanaCincinnati$794K
- Robert OsherCincinnati$720K
- Haroon ChaudhryCincinnati$708K
- Christopher DevineCincinnati$623K
- Robert BenzaCincinnati$224K
- Linda GreffCincinnati$168K
- Karen KlugoCincinnati$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.